Caribou Biosciences Cash Flow Statement (2020-2025) | CRBU

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -9.80M-1.87M-7.93M-14.70M-13.16M-14.31M-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M
Depreciation and Depletion (Quarter) 0.20M0.30M0.20M0.20M0.20M0.30M-0.70M0.30M0.40M
Share-based Compensation (Quarter) 0.29M0.25M0.23M0.34M0.59M0.94M1.58M3.02M2.92M2.67M3.10M3.13M3.58M3.48M3.56M3.99M4.74M4.07M3.91M3.88M3.13M2.93M2.74M
Gains from Investment Securities (Quarter) 0.28M0.38M0.01M2.46M0.14M-0.12M26.25M0.44M0.17M
Asset Writedowns and Impairment (Quarter) 9.20M2.20M
Non-cash Items (Quarter) 6.93M9.29M8.40M4.97M50.09M1.56M31.50M
Cash from Operations (Quarter) -8.69M-8.08M20.31M-16.48M-14.97M-21.39M-21.67M-21.87M-22.38M-25.04M-27.94M-15.19M-28.79M-21.38M-37.20M-32.87M-32.66M-35.47M-36.73M-28.26M-25.22M-20.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.05M-0.33M-0.12M0.34M0.90M1.49M2.10M2.44M-1.62M1.54M0.95M1.22M1.02M0.45M0.29M0.23M0.16M
Depreciation & Amortization (CF) (Quarter) 0.20M0.23M0.22M0.22M0.23M0.26M0.27M0.31M0.36M0.45M0.51M0.59M0.62M1.58M0.74M0.71M0.86M1.18M1.18M1.17M1.17M0.63M0.68M
Change in Working Capital
Change in Receivables (Quarter) 0.38M0.69M1.09M2.80M-3.47M0.57M-1.31M0.68M-2.15M-0.48M-0.55M1.11M-0.43M-0.18M-0.56M0.00M0.59M-0.49M-0.18M0.31M-0.15M-0.17M
Change in Account Payables (Quarter) -2.23M1.95M0.04M0.99M-0.18M0.29M-1.92M-1.64M0.99M-0.15M1.50M0.54M-0.95M0.73M2.72M-2.37M-0.48M-0.23M1.40M-0.63M0.56M1.92M
Change in Accured Expenses (Quarter) 1.59M-1.36M3.88M-3.89M4.87M-0.57M-2.83M3.95M-1.13M1.97M-4.14M3.71M3.28M2.90M-2.20M4.97M1.58M-2.21M-3.10M0.69M-1.11M-2.82M
Other Working Capital Changes (Quarter) -0.88M0.99M29.96M-28.12M28.83M-30.67M-0.09M0.41M1.29M-6.46M-1.10M6.33M-5.52M-16.65M0.76M-0.60M-2.33M2.61M-1.00M-0.85M-0.63M-1.20M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.03M0.02M0.85M-0.60M1.85M0.72M-0.02M0.05M0.47M2.03M0.53M-2.01M11.06M0.85M-0.68M4.19M-3.61M0.12M1.34M-1.46M1.36M
Change in Acquisitions & Divestments (Quarter) 39.30M59.71M64.12M89.74M98.67M72.36M112.17M54.99M97.09M107.80M120.66M71.94M65.95M56.67M68.41M61.79M
Cash from Investing Activities (Quarter) -0.00M-0.60M-0.02M-0.48M-1.93M-173.96M-72.11M-13.97M-8.34M1.17M20.70M11.06M-68.48M-31.47M22.96M21.20M26.52M15.93M49.38M24.04M10.85M17.97M
Financing Activities
Cash from Financing Activities (Quarter) 0.11M0.08M109.68M0.61M322.68M0.46M0.99M0.36M0.65M0.13M1.64M17.57M135.13M-0.04M12.48M0.13M0.24M3.86M0.47M0.01M0.28M4.07M
Additional items
Change in Cash (Quarter) -8.58M-8.59M129.97M-16.35M305.79M-194.89M-92.79M-35.48M-30.06M-23.75M-5.59M13.45M37.86M-52.90M-1.76M-11.53M-5.90M-15.68M13.12M-4.22M-14.06M1.22M
Free Cash Flow (Quarter) -8.71M-8.10M20.29M-17.32M-14.37M-23.24M-22.40M-21.86M-22.43M-25.51M-29.97M-15.72M-26.78M-32.44M-38.05M-32.19M-36.85M-31.86M-36.84M-29.60M-23.76M-22.15M
Net Cash Flow (Quarter) -8.58M-8.59M129.97M-16.35M305.79M-194.89M-92.79M-35.48M-30.06M-23.75M-5.59M13.45M37.86M-52.90M-1.76M-11.53M-5.90M-15.68M13.12M-4.22M-14.09M1.25M